Oramed Pharmaceuticals (ORMP) Research & Development (2011 - 2026)
Oramed Pharmaceuticals (ORMP) posted Research & Development of $1.59 million for Q1 2026, down 27.7% from $2.21 million a year earlier and down 19.8% from the prior quarter.
Oramed Pharmaceuticals (ORMP) Research & Development (2011 - 2026) Analysis & Trends
For FY2025, Oramed Pharmaceuticals' Research & Development came in at $6.38 million, up 0.9% from FY2024.
- Annual Research & Development shows a four-year compound annual growth rate of -25.7% (FY2021 to FY2025).
- In prior years, Oramed Pharmaceuticals' Research & Development was $6.32 million in FY2024 (-29.5%), $8.97 million in FY2023 (-67.5%), $27.64 million in FY2022 and $20.99 million in FY2021.
- Quarterly Research & Development has run from a low of $957,000 in Q3 2023 to a high of $9.18 million in Q2 2022 over five years.
- On a year-over-year basis, Research & Development increased in three of the last eight quarters, with growth averaging 14.3%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2024, with growth of 134.3%; the weakest was Q3 2023, with a decline of 82.1%.
- According to Business Quant data, Research & Development for the three prior quarters was $1.99 million (Q4 2025), $1.15 million (Q3 2025) and $1.03 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Oramed Pharmaceuticals | 168.68 Mn | -166.06 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.59 Mn |
| Dec 31, 2025 | 1.99 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 2.24 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 1.77 Mn |
| Sep 30, 2023 | 957,000.00 |
| Jun 30, 2023 | 1.82 Mn |
| Mar 31, 2023 | 4.43 Mn |
| Dec 31, 2022 | 9.04 Mn |
| Sep 30, 2022 | 5.35 Mn |
| Jun 30, 2022 | 9.18 Mn |
| Mar 31, 2022 | 5.84 Mn |
| Nov 30, 2019 | 2.02 Mn |
| Aug 31, 2019 | 2.20 Mn |
| May 31, 2019 | 3.86 Mn |
Oramed Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ORMP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ORMP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ORMP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();